The Abigail Wexner Research Institute at Nationwide Children's Hospital celebrated the Food and Drug Administration's (FDA) approval of FAYUVI for Sanfilippo syndrome type A, following years of research in its Jerry R. Mendell Center for Gene Therapy to help patients with devastating diseases.
❓ Unknown
FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A
Just now
September 23, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
The FDA approved FAYUVI, the first gene therapy for Sanfilippo syndrome type A, developed by the Abigail Wexner Research Institute at Nationwide Children's Hospital. This approval marks a significant advancement in gene therapy for rare diseases. While the article does not directly relate to Iran, advancements in medical research could influence healthcare policies and gene therapy research in the region.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Iran Indicts Israeli Officials Over Hezbollah Pager Explosions
Just now •
Iran Restores Half of Damaged Natural Gas Production Capacity at South Pars
9 min ago •
Study Reveals Challenges in Detecting Pain from Gastric Ulcers in Horses
13 min ago •
Iran Minimizes Importance of Indirect US Talks Amid Regional Developments
18 min ago •